BlackRock Fund Advisors’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6K Hold
794
﹤0.01% 4042
2016
Q3
$6K Buy
794
+57
+8% +$394 ﹤0.01% 4054
2016
Q2
$5K Buy
737
+64
+10% +$383 ﹤0.01% 4105
2016
Q1
$4K Buy
673
+154
+30% +$1.01K ﹤0.01% 4148
2015
Q4
$3K Buy
+519
New +$3.49K ﹤0.01% 4264

Other funds holding MGCD

BlackRock Fund Advisors's MGCD Position: Q4 2016 in Review

BlackRock Fund Advisors held its MGC Diagnostics Corporation (MGCD) position steady in Q4 2016 at 794 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4042.

BlackRock Fund Advisors first reported a position in MGCD in Q4 2015 and has held it in 5 quarters since. 15 funds tracked by Wall St. Rank hold MGCD as of Q4 2016.

  • BlackRock Fund Advisors held 794 shares of MGC Diagnostics Corporation worth $6K as of Q4 2016.
  • BlackRock Fund Advisors left its MGC Diagnostics Corporation share count unchanged in Q4 2016.
  • MGC Diagnostics Corporation made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4042 holding.
  • BlackRock Fund Advisors first reported a position in MGC Diagnostics Corporation in Q4 2015 and has held it in 5 quarters since.
  • 15 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.